Real ‐world effectiveness of mepolizumab in severe asthma and chronic rhinosinusitis (CRS) in the US: Impact of comorbidity and sinus surgery
ConclusionsConsistent with trial data, mepolizumab use in real-world practice shows benefits across comorbid patient cohorts with more pronounced impact in those with severe asthma+comorbid CRS+sinus surgery.This article is protected by copyright. All rights reserved
Source: International Forum of Allergy and Rhinology - Category: Allergy & Immunology Authors: Jared Silver,
Arijita Deb,
Fran çois Laliberté,
Chi Gao,
Neil Bhattacharyya Tags: ORIGINAL ARTICLE Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Corticosteroid Therapy | Emergency Medicine | Polyps | Study